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Recently, there has been growing interest in applying fluorescence imaging
techniques to the study of various disease processes and complex biological phe-
nomena in vivo. To apply these methods to clinical settings, several groups have
developed protocols for fluorescence imaging using antibodies against tumor
markers conjugated to fluorescent substances. Although these probes have been
useful in macroscopic imaging, the specificity and sensitivity of these methods
must be improved to enable them to detect micro-lesions in the early phases of
cancer, resulting in better treatment outcomes. To establish a sensitive and
highly specific imaging method, we used a fluorophore-conjugated anti-carcino-
embryonic antigen (CEA) antibody to perform macroscopic and microscopic in
vivo imaging of inoculated cancer cells expressing GFP with or without CEA. Mac-
roscopic imaging by fluorescence zoom microscopy revealed that bio-conjugation
of Alexa Fluor 594 to the anti-CEA antibody allowed visualization of tumor mass
consisting of CEA-expressing human cancer cells, but the background levels were
unacceptably high. In contrast, microscopic imaging using a two-photon excita-
tion microscope and the same fluorescent antibody resulted in subcellular-resolu-
tion imaging that was more specific and sensitive than conventional imaging
using a fluorescence zoom microscope. These results suggest that two-photon
excitation microscopy in conjunction with fluorophore-conjugated antibodies
could be widely adapted to detection of cancer-specific cell-surface molecules,
both in cancer research and in clinical applications.
T he survival rates of cancer patients have increaseddramatically over the past a few decades, due to both
improvements in treatments and advances in diagnostic meth-
ods. In particular, early detection of cancer lesions is key to
more favorable prognoses. For example, today almost all
patients with colorectal carcinoma in situ survive beyond
5 years. However, cancer is still a major cause of death, and
metastases and recurrences of cancer are critical issues in treat-
ment.(1) Detection of small lesions in the resection edges and
target organs of metastases, such as lymph nodes, may have
positive effects on treatment outcomes.
Bio-imaging techniques have become indispensable tools in
both biological studies and clinical diagnosis. In recent years,
computed tomography, positron emission tomography, single-
photon emission computed tomography and MRI have become
popular and indispensable methods that are routinely used in
clinical practice and for evaluation of therapeutic efficacy.(2–4)
Although these techniques excel in penetration depth, their
resolution and specificity are not sufficient to detect micro-
lesions, such as cancer in situ or very early phases of lymph-
node metastasis. Fluorescence imaging provides a method for
detection of specific molecules at subcellular resolution that is
potentially superior to conventional imaging modalities; how-
ever, it has not been extensively applied in clinical settings, in
part because of limitations on penetration depth and excessive
background signals.(2–4)
Fluorophore-conjugated antibodies against various targets,
including growth factor receptors, have been used for the
detection of several kinds of cancers in mouse models. Using
these reagents, epidermal growth factor receptor(5) and vascu-
lar endothelial growth factor(6) in head and neck cancers,
HER2(7) in lung metastases, HER1(8) in Her1-overexpressing
intraabdominal cancers and CA19-9(9) in pancreatic cancer
have all been clearly detected, and the use of some of these
fluorophore-conjugated antibodies has improved the rate of
tumor resection at surgery.
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Carcinoembryonic antigen (CEA), a 180-kDa glycosylated
protein produced by various tumors, is widely used as a clini-
cal marker for many different types of human cancer, such as
gastric, colorectal, lung, liver, pancreatic, breast and ovarian
cancer.(10–12) The use of indocyanine green-conjugated anti-
CEA antibody for imaging of human gastric cancer cells has
been described previously, but only in an in vitro context.(13)
Anti-CEA antibody conjugated to another near infrared (NIR)
fluorescent cyanine dye, DY-676, has been tested in vivo.(14)
Although these fluorescent probes are promising, many pre-
vious studies could not completely eliminate problems related
to background signals from intrinsic fluorophores, which may
reduce the sensitivity and specificity of cancer detection. Fur-
thermore, only a few previous studies using fluorophore-conju-
gated antibodies were able to achieve sub-cellular resolution.
Such fine-scale detection could contribute to the improvement
of prognosis of cancer patients by identifying micro-lesions in
the early phases of primary and metastatic cancers.
Two-photon excitation microscopy has been widely used to
analyze various phenomena in living animals.(15,16) Because
longer wavelengths are used for two-photon excitation of flu-
orophores than for conventional methods of fluorescence imag-
ing, this technique has many advantages, including better
penetration depth, higher signal-to-background ratio and
reduced tissue damage. Together, these features enable imag-
ing of deep tissue at high spatiotemporal resolution.
In this study, we performed in vivo cancer imaging in mouse
models, using a fluorophore-conjugated anti-CEA antibody in
two-photon excitation microscopy, to achieve subcellular reso-
lution. In the future, the method we have developed could be
applied in clinical settings.
Materials and Methods
Cell lines and establishment of HT1080-GFP-CEA and MKN45-
GFP cells. HT1080 human fibrosarcoma cells expressing GFP
were established as described previously.(17,18) To establish
HT1080-GFP cells expressing CEA (HT1080-GFP-CEA),
pcCAG-CEA was constructed by inserting the human CEA
cDNA, cloned from mRNA of MKN45, into vector pcCAG, a
modified version of vector pcDEF3(19) in which the EF-1a
promoter is replaced by the CAG promoter. HT1080-GFP
cells were transfected with pcCAG-CEA and selected with
0.8 mg ⁄mL G418 for 7 days, and then cells expressing high lev-
els of CEA were enriched by two rounds of FACS as described
below. Control HT1080-GFP cells were also established by
transfection with empty pcCAG vector, followed by selection
with 0.8 mg ⁄mL G418 for 7 days. MKN45 human gastric can-
cer cells were obtained from the American Tissue Culture
Collection (Manassas, VA, USA). To establish MKN45 cells
expressing GFP (MKN45-GFP), we used a lentiviral expression
system as described previously.(18,20) HT1080 and HeLa cells
were maintained in DMEM containing 10% FBS supplemented
with 100 U ⁄mL penicillin G and 100 lg ⁄mL streptomycin, and
MKN45 and MKN28 cells were maintained in RPMI1640 med-
ium containing 10% FBS supplemented with 100 U ⁄mL penicil-
lin G and 100 lg ⁄mL streptomycin. All cells were cultured at
37°C in an atmosphere containing 5% CO2. HeLa and MKN28
cells were used as CEA-negative controls.
Immunoblotting. Cells were lysed with Nonidet P-40 (NP-40)
lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% NP-
40). Extracted proteins were separated by SDS-PAGE in 10%
(w ⁄v) polyacrylamide gels, and then electro-transferred onto
polyvinylidene difluoride (PVDF) membranes. Immunoblotting
was performed by incubating the membranes with anti-CEA pri-
mary antibody (1:1000 dilution, #2383, CEA ⁄CD66e [CB30]
mouse mAb [Cell Signaling Technology, Tokyo, Japan]) for 1 h
at room temperature, and then with horseradish peroxidase
(HRP)-conjugated goat anti-mouse IgG secondary antibody
(1:5000 dilution) for 1 h at room temperature. Specific protein
bands were visualized by chemiluminescence (ECL Prime Wes-
tern Blotting Detection System; GE Healthcare Japan, Tokyo,
Japan). b-actin, used as an internal control, was detected with a
specific antibody (1:2000 dilution, AC-74; Sigma-Aldrich Japan,
Tokyo, Japan) in the same manner.
Flow cytometry analysis and FACS analysis. HT1080-GFP-
CEA cells and MKN45 cells were suspended in 2 mM EDTA
in PBS, and then washed twice with PBS. Immunostaining
was performed by incubating the cells with anti-CEA primary
antibody (1:200 dilution, #2383; Cell Signaling Technology)
for 1 h on ice, and then with Alexa Fluor 647-conjugated
secondary antibody (1:2000 dilution, #A-21235, Alexa Fluor
647 Goat Anti-Mouse IgG (H+L); Invitrogen, Tokyo, Japan)
for 1 h on ice. Flow cytometry analysis and cell sorting were
performed on a BD FACSAria II cell-sorting system (Becton–
Dickinson, Tokyo, Japan).
Immunostaining for in vitro fluorescence imaging. HT1080-
GFP-CEA, HT1080-GFP, and MKN45-GFP cells were
cultured on a cover slip and washed once with PBS. The cells
were incubated with 4% (w ⁄v) paraformaldehyde (PFA) and
washed three times with PBS, followed by incubation with
anti-CEA primary antibody (1:200 dilution, #10094, Anti-
Human CEA (1B2) Mouse IgG mAb; IBL, Gunma, Japan)
overnight at 4°C. The cells were then washed three times with
PBS, followed by incubation with Alexa Fluor 594-conjugated
secondary antibody (1:2000 dilution, #A-11005, Alexa Fluor
594 Goat Anti-Mouse IgG [H+L] Antibody; Invitrogen) for
30 min at room temperature. Fluorescence images of the cells
were captured with a confocal microscope (objective: 960;
excitation wavelengths: 488 and 561 nm; A1R+ confocal
microscope system; Nikon, Tokyo, Japan). Image contrast was
adjusted by look-up tables (LUTs) in the software of the
microscope (NIS-Elements ver. 4.0; Nikon) under the same
condition in each image.
Animal models. All animal procedures were approved by the
Committee on Animal Experimentation at Ehime University
School of Medicine (#05-RE-1-16) and performed in the ani-
mal experiment room of Ehime University according to the
guidelines proposed by the Science Council of Japan. Female
BALB ⁄ c nu ⁄nu mice (4–8 weeks old) were purchased from
Charles River Japan (Kanagawa, Japan). All in vivo experi-
ments were performed on anesthetized mice with a ketamine
⁄xylazine cocktail (35–70 mg ⁄kg: 6–12 mg ⁄kg body weight)
via i.p. injection. For the s.c. inoculation model, HT1080-
GFP-CEA, HT1080-GFP and MKN45-GFP cells were inocu-
lated s.c. into the mice (1 9 106 cells in 100 lL of culture
medium). Seven or eight days after the inoculation, the dorsal
skin of the mice was surgically opened to observe the tumor
mass on the skin flap. For the pre-incubation experiment,
MKN45-GFP cells were immunostained prior to inoculation by
overnight incubation with anti-CEA primary antibody (1:200
dilution, #10094; IBL) bound to Alexa Fluor 594-conjugated
anti-mouse IgG secondary antibody (1:2000 dilution,
#Z-25107, Zenon Alexa Fluor 594 Mouse IgG2a Labeling Kit;
Invitrogen). Skin flaps were prepared in the mice as described
above, followed by inoculation of 0, 104, 105 or 106 cells in
50 lL of 1% agarose into the connective tissue of each skin
flap. For the footpad spontaneous metastasis model, 2 9 106
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HT1080-GFP-CEA cells in 20 lL of culture medium were
injected into right footpads of the mice. Four weeks after the
inoculation, mice were laid in the prone position and the legs
were fixed, taking care not to stimulate the tumor. A straight
incision of 1 cm was then made in the ipsilateral popliteal
region.(21) The popliteal lymph node was exposed and sub-
jected to macroscopic ⁄microscopic observation and histological
examination.
In vivo macroscopic imaging using a fluorescence zoom micro-
scope. In the s.c. inoculation model and footpad spontaneous
metastasis model, tumors were imaged 24 h after injection of
Alexa 594-conjugated anti-CEA antibody (10 or 50 lg ⁄body)
via the tail vein. For the pre-incubation experiment, images
were acquired immediately after inoculation. In vivo macro-
scopic imaging was performed using a fluorescence zoom
microscope (MULTIZOOM AZ100; Nikon) with a GFP-HQ
filter set (for GFP) and a Texas Red filter set (for Alexa Fluor
594), and an AZ-Plan Apo 0.59 Plan Fluor objective lens
(Nikon). All images were collected with a monochrome digital
charge-coupled device camera (C9100–13, ImagEM Enhanced;
Hamamatsu Photonics, Shizuoka, Japan).
In vivo microscopic imaging using a two-photon excited micro-
scope. After in vivo macroscopic imaging, tumors were sub-
jected to in vivo microscopic imaging by two-photon
excitation microscopy, as follows. The tumor mass on the skin
flap was observed by upright microscopic system (Suppl. Fig.
S1). Image acquisition was performed by a water-immersion
objective lens. Tumors were surrounded by agarose gel and
submerged in saline during the observation. Two-photon
excited fluorescence imaging and second harmonic generation
(SHG) imaging were performed using a multiphoton micros-
copy system (A1R+MP; Nikon) with a water-immersion objec-
tive lens (CFI75 Apo 25xW MP, numerical aperture: 1.1;
Nikon) and an excitation laser (wavelengths: 680–950 nm;
repetition rate: 80 MHz; pulse width: 70 fs [MaiTai eHP,
Spectra-Physics, CA, USA]). An excitation wavelength of 780
or 800 nm was used for the image acquisition. Emission filters
were as follows: 629 ⁄56 nm band-pass for Alexa Fluor 594,
525 ⁄50 nm band-pass for GFP and 492 nm short-pass for
SHG. Image acquisition and processing for 3-D rendering were
performed using NIS-Elements version 4.0 (Nikon). Image
contrast was adjusted by LUTs in the NIS-Elements version
4.0 (Nikon) under the same condition in each image.
Immunofluorescence on tissue sections. In the footpad sponta-
neous metastasis model, the popliteal lymph node was
resected, fixed with 4% (w ⁄v) PFA overnight at 4°C, and
embedded in paraffin. Five-micron sections were deparaffi-
nized and subjected to HE staining and immunofluorescence.
For immunofluorescence, anti-CEA antibody (1:200 dilution,
#10094, IBL) and anti-GFP antibody (1:1000 dilution, #04404-
26, anti-GFP [Rat IgG2a] monoclonal [GF090R]; Nacalai
Tesque, Tokyo, Japan) were used as primary antibodies. The
sections were then washed three times in Tris-buffered saline
with Tween 20 (TBS-T; 50 mM Tris-HCl [pH 7.6], 150 mM
NaCl, 0.1% Tween 20), followed by incubation at room tem-
perature for 3 h with Alexa Fluor 568-conjugated anti-mouse
IgG (1:500 dilution, #A-11004, Alexa Fluor 568 Goat Anti-
Mouse IgG [H+L] Antibody; Invitrogen) and Alexa Fluor 488-
conjugated anti-mouse IgG (1:500 dilution, #A-11006, Alexa
Fluor 488 Goat Anti-Rat IgG (H+L) Antibody; Invitrogen) as
the secondary antibodies. Fluorescence and differential inter-
ference contrast images of the sections were observed with a
wide-field fluorescence microscope (PlanApo 209 ⁄0.75, Pla-
nApo 409 ⁄ 0.95, ECLIPSE 80i; Nikon).
Results
Establishment of GFP-expressing and carcinoembryonic anti-
gen-expressing human cancer cells and in vitro fluorescence
imaging. To characterize and evaluate fluorophore-conjugated
anti-CEA antibody for macroscopic and microscopic cancer
imaging by two-photon excitation microscopy, we first estab-
lished CEA-expressing HT1080 human fibrosarcoma cells, and
then performed immunoblotting analysis to compare expression
of CEA protein among the CEA-expressing HT1080 cells
(HT1080-GFP-CEA), control HT1080-GFP cells and MKN45
human gastric cancer cells (MKN45-GFP). As shown in
Figure 1(a), MKN45-GFP cells expressed abundant endoge-
nous CEA protein; HT1080-GFP-CEA cells expressed a lower
level of exogenous CEA protein; and HT1080-GFP, HeLa and
MKN28 cells expressed undetectable levels of endogenous
CEA protein.
We then performed FACS analysis to investigate the expres-
sion of cell-surface CEA protein in HT1080-GFP-CEA and
MKN45-GFP cells (Fig. 1b). After two rounds of FACS sort-
ing, the peak of the histogram of HT1080-GFP-CEA (red line)
nearly overlapped that of MKN45-GFP (gray line). After only
a single round of sorting, HT1080-GFP-CEA (orange line) had
a sub-peak near the peak of the histogram of the negative con-
trol (blue line). These results indicate that HT1080-GFP-CEA
cells express levels of cell-surface CEA protein similar to
those of MKN45 cells.
We next tried to visualize cell-surface CEA protein in
HT1080-GFP-CEA and MKN45-GFP cells by fluorescence
imaging. To this end, we immunostained cells with anti-CEA
antibody and observed them by confocal microscopy (Fig. 1c–
e). The fluorescence images confirmed comparable in vitro
expression of CEA protein on the surfaces of MKN45-GFP
(Fig. 1c) and HT1080-GFP-CEA cells (Fig. 1d), but not
HT1080-GFP cells (Fig. 1e).
To demonstrate the localization of the CEA protein on the
CEA-expressing cells, we provide magnified images of the im-
munostaining in Supplementary Figure S2. CEA protein on the
cell surface (i.e. localized on the plasma membrane) was
clearly detected in MKN45-GFP cells and HT1080-GFP-CEA
cells. Thus, MKN45-GFP and HT1080-GFP-CEA cells express
comparable levels of cell-surface CEA protein that can be spe-
cifically recognized by the anti-CEA antibody.
In vivo fluorescence macroscopic imaging of tumor masses of
CEA-expressing human cancer cells using an Alexa Fluor 594-con-
jugated anti-CEA antibody. Next, we attempted to visualize
tumor masses of HT1080-GFP-CEA and MKN45-GFP cells in
vivo, using an Alexa Fluor 594-conjugated anti-CEA antibody.
HT1080-GFP, HT1080-GFP-CEA, and MKN45-GFP cells
were s.c. implanted into immunodeficient nude mice, and then
Alexa Fluor 594-conjugated anti-CEA antibody was injected
into tail vein 7 days after inoculation. Twenty-four hours after
the injection, fluorescence macroscopic (macro-scale) images
were acquired using a fluorescence zoom microscope after the
skin flap operation (Fig. 2a,b).(22) In the macroscopic images,
tumor formation could be confirmed at all the inoculation sites
in both the bright field (BF) and GFP images. Although the
fluorescence signals in the surrounding tissues were high,
tumor masses of CEA-expressing cells (MKN45-GFP and
HT1080-GFP-CEA) could be clearly detected in the Alexa
Fluor 594 image (Fig. 2c–e). However, the intensity of the
Alexa Fluor 594 fluorescence signal in the tumor mass of
CEA-negative cells was not significantly different from that in
surrounding tissues. These results suggest that Alexa Fluor
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594-conjugated anti-CEA antibody could specifically visualize
tumor masses of CEA-expressing human cancer cells in vivo,
but the background signals of the surrounding tissues must be
distinguished from those of the tumor mass.
In vivo microscopic fluorescence imaging of anti-carcinoembry-
onic antigen-expressing human cancer cells using an Alexa
Fluor 594-conjugated anti-carcinoembryonic antigen anti-
body. Two-photon excitation microscopy enables collection of
fluorescence images in deep tissues at subcellular resolution,
as well as capture of nonlinear optical process such as SHG in
living tissues.(23) We attempted to visualize the inoculated
HT1080-GFP-CEA and MKN45-GFP cells at subcellular reso-
lution, in the same tumors shown in Figure 2, by two-photon
excitation microscopy using Alexa Fluor 594-conjugated anti-
CEA antibody. GFP signals from three cell lines were detected
as shown in the 3-D (Fig. 3a–c) and 2-D reconstructions
(Fig. 3d–f) of fluorescence images. In addition, SHG signals
were generated from peripheral tissues of the tumors, and to a
lesser extent in the tumor stroma. HT1080-GFP-CEA (Fig. 3b,
e) and MKN45 cells (Fig. 3c,f), but not HT1080-GFP cells
(Fig. 3a,d), could be recognized by the Alexa Fluor 594-
conjugated anti-CEA antibody in vivo. In the tumor masses of
CEA-expressing cells (HT1080-GFP-CEA and MKN45-GFP
cells), the Alexa Fluor 594 fluorescence signal was mainly
observed on the surfaces of the cancer cells expressing GFP
fluorescence in the cytoplasm, but the signal was also detected
in the surrounding tissue not containing cancer cells, for exam-
ple, connective tissue on the tumor surfaces, as depicted by
(a) (b)
(c) (d) (e)
Fig. 1. Establishment of GFP and
carcinoembryonic antigen (CEA)-expressing human
cancer cells and in vitro fluorescence imaging.
Comparable expression of CEA protein in HT1080-
GFP-CEA and MKN45-GFP cells was confirmed by
western blotting, flow cytometry analysis and
immunostaining. (a) Western-blotting analysis of
CEA expression. HT1080-GFP-CEA cells, subjected to
one or two rounds of FACS, were subjected to
western blotting alongside MKN45-GFP (CEA-
positive) and HeLa, MKN28 and HT1080-GFP (CEA-
negative) cells. (b) Flow cytometry analysis of cells
expressing CEA. HT1080-GEP-CEA cells were
subjected to one or two rounds of FACS, and then
analyzed by flow cytometry alongside MKN45-GFP
cells. (c–e) Immunostaining of cells to detect CEA.
MKN45-GFP (c), HT1080-GFP-CEA (sorted twice) (d)
and HT1080-GFP (e) cells were immunostained with
anti-CEA primary antibody and Alexa Fluor 594-
conjugated anti-mouse IgG secondary antibody
(red), and then observed by confocal microscopy
(objective: 960; excitation: 488 nm for GFP and
561 nm for Alexa Fluor 594). Green indicates the
GFP fluorescence signal.
(a) (b)
(c) (d) (e)
Fig. 2. Inoculation of human cancer cells into
immunodeficient mice and in vivo macroscopic
imaging using a fluorescence zoom microscope. (a)
Schema of the sites of inoculation of human cancer
cells. The cells were inoculated s.c. into the back
skin of nude mice at the rostral–ventral site
(HT1080-GFP cells), the caudal–ventral site (HT1080-
GFP-CEA cells) or the dorsal site (MKN45-GFP cells).
(b) Schema of preparation of skin flaps. Seven or
eight days after the inoculation, the inoculation
sites were exposed by the skin-flap method. (c–e) In
vivo macro imaging of tumors. In vivo macro
imaging of the tumor masses was performed using
a fluorescence zoom microscope 24 h after
injection of Alexa Fluor 594-conjugated anti-CEA
antibody (50 lg ⁄ mouse). Exposure times for the
GFP and Alexa Fluor 594 fluorescence images were
30 and 100 ms, respectively. These experiments
were repeated three times and similar results were
obtained.
© 2014 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd
on behalf of Japanese Cancer Association.
Cancer Sci | October 2014 | vol. 105 | no. 10 | 1302
Original Article
In vivo tumor imaging by two-photon excitation microscopy www.wileyonlinelibrary.com/journal/cas
the SHG signal. In CEA-negative cells, the Alexa Fluor 594
fluorescence signal was detected predominantly in surrounding
tissue lacking cancer cells.
Moreover, the magnified images of Figure 3(d–f) confirmed
that the anti-CEA antibody recognized target proteins localized
on the plasma membrane of CEA-expressing cells, resulting in
a ring-shaped pattern of fluorescence (Fig. 3g–i). In addition,
background signals could be dramatically reduced by decreas-
ing the amount of injected antibody from 50 to 10 lg, while
the resultant signals could not be detected by macroscopic
imaging (Suppl. Fig. S3 and data not shown). In these two-
photon excitation microscopy experiments, the penetration
depths in the tumor mass were typically 300–700 lm (data not
shown). These results suggest that the combination of Alexa
Fluor 594-conjugated anti-CEA antibody and two-photon exci-
tation microscopy enables specific visualization of CEA pro-
tein on the cell surface of human cancer cells in vivo. Signals
from the surfaces of tumor cells could be readily distinguished
from those from non-target tissues by their distribution in the
tumor mass. Moreover, the characteristic ring-shaped pattern
of the signal may be a hallmark of tumor cells expressing
CEA on their membrane surfaces. Notably, this feature can
only be visualized when subcellular resolution is achieved.
Detection of small numbers of anti-carcinoembryonic antigen-
expressing human cancer cells in vivo by two-photon excitation
microscopy. In order to evaluate the ability of fluorescence-
microscopic imaging by two-photon excitation microscopy to
detect small numbers of cancer cells labeled with fluorophore-
conjugated antibody in vivo, MKN45-GFP cells were pre-incu-
bated with Alexa Fluor 594-conjugated anti-CEA antibody
overnight, and then 0, 104, 105 or 106 of these cells in 50 lL
of 1% agarose were inoculated into the connective tissue of
skin flaps (Suppl. Fig. S4). Just after inoculation, macroscopic
images were acquired using a fluorescence zoom microscope.
As shown in Supplementary Figure S5(a–c), tumor masses of
MKN45-GFP cells could be detected by the fluorescence zoom
microscope only when 106 cells were inoculated. Next, to visu-
alize the same tumors shown in Supplementary Figure S5 at
subcellular resolution, we performed two-photon excitation
microscopy imaging. 3-D reconstructions (Fig. 4a–d) and the
cropped 3-D images (Fig. 4e–h) from two-photon excitation
microscopy images revealed that this method allowed MKN45-
GFP cells to be detected much more sensitively not only when
106 (Fig. 4d,h and Suppl. Fig. S6c), but also 104 (Fig. 4b,f and
Suppl. Fig. S6a) and 105 (Fig. 4c,g and Suppl. Fig. S6b) of the
cells were inoculated. In the two-photon experiment, the pene-
tration depths reached within the tumor mass were almost
2 mm. These results suggest that two-photon excitation
microscopy using fluorophore-conjugated anti-CEA antibody
can achieve deeper and more sensitive cancer cell imaging in
vivo than conventional imaging using a fluorescence zoom
microscope.
In vivo fluorescence microscopic imaging of lymph-node metas-
tases by carcinoembryonic antigen-expressing human cancer cells
using the Alexa Fluor 594-conjugated anti-carcinoembryonic anti-
gen antibody. Finally, to further test the usefulness of this
combination of two-photon excitation microscopy and fluoro-
phore-conjugated anti-CEA antibody in a more clinically rele-
vant setting, we used this method to detect lymph-node
metastases containing HT1080-GFP-CEA cells in vivo. In a
footpad spontaneous metastasis model using HT1080-GFP-
CEA cells, we observed the popliteal lymph node by fluores-
cence zoom microscopy (Fig. 5a–c) and two-photon excitation
microscopy (Fig. 5d–f), respectively. In macroscopic images,
lymph-node metastasis could be clearly identified by the GFP
fluorescence signal (Fig. 5b); however, contrary to our expec-
tations, the Alexa Fluor 594 signal was not detectable
(Fig. 5c). In contrast, in two-photon excitation microscopy, flu-
orescence of both GFP and Alexa Fluor 594 from the tumor
cells in the lymph node could be detected in vivo (Fig. 5d–f).
We also validated the lymph-node metastasis model by per-
forming immunofluorescence on histological sections (Suppl.
Fig. S7). Histologically, metastatic foci occupied small regions
inside the lymph nodes, as revealed by HE staining (Suppl.
Fig. S7a). Likewise, expression of GFP and CEA protein could
be detected in regions of lymph nodes in immunofluorescence
images (Suppl. Fig. S7b). These data are consistent with those
obtained by two-photon excitation microscopy in vivo, which
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Fig. 3. In vivo fluorescence imaging using a two-
photon microscope. After the in vivo macroscopic
imaging as shown in Figure 2(c–e), the same tumors
were observed by two-photon excitation
microscopy. (a–f) 3-D and 2-D images of HT1080-
GFP (a, d), HT1080-GFP-CEA (b, e) and MKN45 (c, f)
cells were acquired by two-photon excitation
microscopy. Each 2-D image represents an
orthogonal view: x-y (center panel), y-z (left panel)
and x-z (lower panel). Red, green and blue indicate
Alexa Fluor 594 fluorescence, GFP fluorescence and
second harmonic generation (SHG), respectively.
(g–i) Magnified images of (d–f).
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revealed co-localization of GFP and CEA proteins within
lymph nodes. These results suggest that use of fluorophore-
conjugated anti-CEA antibody in two-photon excitation
microscopy can be adapted to preclinical models to detect
micrometastasis of tumor cells in vivo.
Discussion
Fluorophore-conjugated antibodies against several cell mem-
brane proteins expressed by cancer cells are very useful for
specific detection of several cancers in mouse models, as well
as in human patients in the clinic.(24,25) In this study, to
evaluate macroscopic and microscopic imaging of cancer in
mouse models in conjunction with a fluorophore-conjugated
antibody, we first established GFP-expressing and CEA-
expressing human cancer cell lines, and then demonstrated that
cell-surface expression of CEA was comparable in MKN45-
GFP cells and FACS-sorted HT1080-GFP-CEA cells. Next,
using these cells and control HT1080-GFP cells, we demon-
strated that the anti-CEA antibody conjugated to Alexa Fluor
594 could specifically visualize tumor masses of CEA-express-
ing human cancer cells under the fluorescence zoom micro-
scope. However, the results of macroscopic fluorescence
imaging were confounded by high background signals originat-
ing from non-target tissues. Of note, fluorescent probes that
can be activated only in tumor cells will enable tumor imaging
with greater specificity.(26)
The ultimate aim of cancer imaging is visualization of can-
cers with sufficient specificity and sensitivity to be of clinical
usefulness.(3,4) To achieve this, we adopted two-photon excita-
tion microscopy for microscopic imaging of cancer cells using
an Alexa Fluor 594-conjugated anti-CEA antibody. Although
signals potentially originating from the fluorophore-conjugated
antibody were detected in tumor stroma of both CEA-positive
and CEA-negative tumors (Fig. 3), signals from the surfaces
of tumor cells could be distinguished by their characteristic
ring-shaped pattern. These results demonstrated that two-pho-
ton excitation microscopy could improve the specificity of
tumor imaging by enabling visualization of probes at subcellu-
lar resolution.
(a) (b) (c) (d)
(e) (f) (g) (h)
3-D
3-D
Fig. 4. In vivo fluorescence micro imaging of small
numbers of cancer cells by two-photon excitation
microscopy. In vivo micro imaging of the
inoculation sites was performed after injection of
immunostained MKN45-GFP cells pre-incubated
with Alexa Fluor 594-conjugated anti-CEA antibody
(see Suppl. Fig. S4). (a–d) 3-D images of sites
inoculated with 0 (a and e), 104 (b and f), 105 (c
and g) or 106 (d and h) MKN45-GFP cells were
acquired by two-photon excitation microscopy. (e–
h) Cropped 3-D images of (a–d). The top and
bottom of the cropped 3-D images are indicated
with two white arrowheads in (a–d). Red, green
and blue indicate Alexa Fluor 594 fluorescence, GFP
fluorescence and second harmonic generation
(SHG), respectively.
(a) (b) (c)
(d) (e) (f)
Fig. 5. In vivo fluorescence macroscopic and
microscopic imaging of lymph-node metastases by a
fluorescence zoom microscope and a two-photon
excitation microscope. (a–c) A footpad spontaneous
metastasis model using HT1080-GFP-CEA cells
observed by a fluorescence zoom microscope. The
popliteal lymph node was exposed, and multiple
images were collected: bright field image (a), GFP
(b) and Alexa Fluor 594 (c). Exposure times for the
GFP and Alexa Fluor 594 images were 1000 and
3000 ms, respectively. (d–f) Two-photon excitation
microscopy of the popliteal lymph node. After
in vivo macroscopic imaging, the same lymph node
was observed using a two-photon excitation
microscope. Acquired images are shown as 3-D
construction (d), cropped 3-D image of Figure 5d
(e) and magnified image of Figure 5e (f),
respectively. Red, green and blue indicate Alexa
Fluor 594 fluorescence, GFP fluorescence and
second harmonic generation (SHG), respectively.
© 2014 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd
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Another advantage of our technique is better sensitivity. In
the experiments depicted in Figure 4, small numbers of cells
labeled with a fluorescent probe were inoculated into nude
mice at various concentrations. By macroscopic fluorescence
imaging, the limit of detection was a 106 cells ⁄50 lL. In con-
trast, much lower concentration (104 cells ⁄50 lL) could be
visualized at subcellular resolution by two-photon excitation
microscopy, confirming the greater sensitivity of this tech-
nique. The improved sensitivity was further confirmed in
Figure 5, a situation closer to the clinical setting.
Moreover, two-photon excitation microscopy allows intravi-
tal imaging with greater penetration and lower toxicity than
conventional fluorescence imaging tools such as confocal
microscopy.(27) In fact, using two-photon excitation micros-
copy, we could detect inoculated cancer cells in agarose at
penetration depths of nearly 2 mm (Fig. 4), although it must
be acknowledged that the areas of observation were filled
mostly with agarose. In solid tumor masses, penetration depths
were typically several hundred micrometers, which cannot be
reached by confocal microscopy.
Considering the advantages of two-photon microscopy
described above, we propose that this technique, in combina-
tion with fluorescence probes that are safe to use in the
human body, could be applied to detection of micro-lesions
in clinical settings, for example, carcinoma in situ, remaining
cancer cells on the resection borders of tumor specimens, and
in early phases of lymph-node metastases. At present, these
lesions are examined using conventional pathological proce-
dures. Pathological examination has an advantage over fluo-
rescence imaging in that it has no limitation of penetration
depth as long as the specimen can be resected. However,
fluorescence imaging has the advantage that it enables exami-
nation of organs without causing unnecessary damage, which
is especially important when the suspicious lesions are not, in
fact, malignant.
To facilitate the clinical application of this combination of
techniques, it will be necessary to further improve penetration
depth and reduce background. One possible solution to this
problem would be to use NIR fluorescent substances. Some
groups have reported the superiority of NIR fluorophores in
regard to signal-to-noise ratio and penetration depth. NIR
probes approved for clinical use are yet to be developed.
In conclusion, two-photon excitation microscopy in conjunc-
tion with fluorophore-conjugated antibodies has advantages
over conventional fluorescence microscopy in regard to speci-
ficity, sensitivity and penetration depth. This combination of
techniques could be widely adapted to detection of cancer-spe-
cific cell-surface molecules, in both cancer research and clini-
cal applications.
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